Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector

Naci, Huseyin ORCID: 0000-0002-7192-5751, Carter, Alexander W. and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2015) Double failure: the shared accountability of governments and firms for the innovation deficit in the pharmaceutical sector. BMJ. ISSN 1756-1833

PDF - Accepted Version Registered users only Download (481kB)

• Author

Abstract

Despite the large number of new medicines entering the market every year, the vast majority offer few clinical advantages for patients over existing alternatives. Governments and pharmaceutical companies share the responsibility for this innovation deficit in the sector

Item Type:	Article
Official URL:	https://www.bmj.com/bmj/section-pdf/909535?path=/b...
Additional Information:	© 2015 BMJ Publishing Group Ltd
Divisions:	Social Policy LSE Health
Subjects:	R Medicine > RS Pharmacy and materia medica
Date Deposited:	29 Oct 2015 09:39
Last Modified:	01 Oct 2024 03:42
URI:	http://eprints.lse.ac.uk/id/eprint/64215

Actions (login required)

View Item